Drug Trial Radar · NCT02965456
Efficacy and Safety of IDP-121 and IDP-121 Vehicle Lotion in the Treatment of Acne Vulgaris
Last checked: Nov 19, 2026Latest source record: Dec 18, 2019 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
820
Actual
Start
Nov 4, 2015
Primary completion
Feb 23, 2017
Study completion Feb 23, 2017
Sponsor
- Lead sponsor
- Bausch Health Americas, Inc.Industry
- Sponsor type
- Industry
- First posted
- Nov 16, 2016
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 9 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The objective of this study was to evaluate the efficacy, safety, and tolerability of a once daily topical application of IDP-121 Lotion compared with its vehicle (IDP-121 Vehicle Lotion) in participants with moderate to severe acne vulgaris (acne) (that is, acne having an Evaluator's Global Severity Score \[EGSS\] of 3 \[moderate\] or 4 \[severe\]).
Conditions
- Acne
Interventions
IDP 121 LotionDrug
IDP-121 lotion will be applied as per the instructions provided by the investigational center staff.
IDP-121 Vehicle LotionDrug
IDP-121 vehicle lotion will be applied as per the instructions provided by the investigational center staff.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Absolute Change From Baseline in Mean Noninflammatory Lesion Count to Week 12Time frame: Baseline (Day 0), Week 12
- Absolute Change From Baseline in Mean Inflammatory Lesion Count to Week 12Time frame: Baseline, Week 12
- Percentage of Participants With Treatment Success at Week 12Time frame: Baseline, Week 12
Locations
34 sites in 1 country. Site status is shown where the registry gives one.
Valeant Site 21
Glendale, Arizona
Valeant Site 34
Rogers, Arkansas
Valeant Site 25
Anaheim, California
Valeant Site 18
Beverly Hills, California
Valeant Site 09
Fremont, California
Valeant Site 17
Murrieta, California
Valeant Site 26
Oxnard, California
Valeant Site 22
Sacramento, California
Valeant Site 02
San Diego, California
Valeant Site 04
San Diego, California
Valeant Site 19
Santa Monica, California
Valeant Site 15
Miami, Florida
Valeant Site 11
Miami, Florida
Valeant Site 27
Pinellas Park, Florida
Valeant Site 31
Sanford, Florida
Valeant Site 05
Tampa, Florida
Valeant Site 28
Marietta, Georgia
Valeant Site 16
Buffalo Grove, Illinois
Valeant Site 06
Indianapolis, Indiana
Valeant Site 12
Overland Park, Kansas
Valeant Site 32
Crowley, Louisiana
Valeant Site 30
Clarkston, Michigan
Valeant Site 03
Detroit, Michigan
Valeant Site 20
Henderson, Nevada
Valeant Site 08
New York, New York
Valeant Site 23
Winston-Salem, North Carolina
Valeant Site 29
Hazleton, Pennsylvania
Valeant Site 24
Johnston, Rhode Island
Valeant Site 10
Austin, Texas
Valeant Site 01
Houston, Texas
Valeant Site 33
Port Arthur, Texas
Valeant Site 07
San Antonio, Texas
Valeant Site 13
San Antonio, Texas
Valeant Site 14
San Antonio, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.